The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life.
Open accessAbstract
The Medical Research Council's trial of BCG and vole bacillus vaccines in the prevention of tuberculosis in Great Britain has ended after 20 years' follow-up of the 54 239 participants, who were aged 14 to 15 years when the entered the trial in 1950-2. Participants who were tuberculin positive on entry were left unvaccinated; those who were tuberculin negative were allocated at random to an unvaccinated or to a vaccinated group. The protective efficacy of each of the two vaccines, among those initially tuberculin negative, was 84% during the first five years, and gradually decreased, averaging 77% for each vaccine over the whole period. The incidence of tuberculosis decreased substantially in all groups during the trial, however, and of the total of 610 cases of tuberculosis only 27 developed between 15 and 20 years. Thus we cannot make a reliable assessment of efficacy during this final period. The prevalence and incidence of tuberculosis in Great Britain have decreased radically since this trial began. The expected benefit from large-scale BCG-vaccination of children is now far less, and may decrease further if the incidence of tuberculosis continues to decline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis.
Palmer, C., & Long, M. W. (1966) · PubMed · doi:10.1164/arrd.1966.94.4.553 · Cited by 292
Community trials of BCG vaccination.
Palmer, C. E., SHAW, L. W., & Comstock, G. W. (1958) · PubMed · doi:10.1164/artpd.1958.77.6.877 · Cited by 111
A Twenty-Year Appraisal of BCG Vaccination in the Control of Tuberculosis
Aronson, J. D. (1958) · Archives of Internal Medicine · doi:10.1001/archinte.1958.00260170037006 · Cited by 102
Sutherland, I., Mitchell, D. N., & Hart, P. D. (1965) · BMJ · doi:10.1136/bmj.2.5460.497 · Cited by 40
Self-citationSpringett, V. H., & Sutherland, I. (1970) · BMJ · doi:10.1136/bmj.4.5728.148 · Cited by 30
Self-citation
Cited by
Variation in protection by BCG: implications of and for heterologous immunity
Fine, P. E. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92348-9 · Cited by 1,380
BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis
Kaufmann, E., Sanz, J., Dunn, J. L., Khan, N., Mendonça, L. E., Pacis, A., Tzelepis, F., Pernet, E., Dumaine, A., Grenier, J.-C., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.031 · Cited by 1,191
Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials
Mangtani, P., Abubakar, I., Ariti, C., Beynon, R., Pimpin, L., Fine, P. E. M., Rodrigues, L. C., Smith, P. G., Lipman, M., Whiting, P. F., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit790 · Cited by 995
The success and failure of BCG — implications for a novel tuberculosis vaccine
Andersen, P., & Doherty, T. M. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1211 · Cited by 788
Pym, A. S., Brodin, P., Brosch, R., Huerre, M., & Cole, S. T. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03237.x · Cited by 729
“Mycobacterium microti is host restricted and naturally attenuated for humans, yet protects against tuberculosis as well as BCG does (Sula and Radkovsky, 1976; Hart and Sutherland, 1977).”
BackgroundInfluential
Metadata
- Authors
- Hart, P. D., & Sutherland, I.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1977-07-30
- Volume
- 2
- Issue
- 6082
- Pages
- 293-295
- ISSN
- 0007-1447 (ISSN-L)
- 1468-5833
- OpenAlex
- W2050862002
- Cited by
- 519
- References
- 5
- FWCI
- 6.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.